Global X Genomics & Biotechnology ETF
GNOM
6 hedge funds and large institutions have $9.83M invested in Global X Genomics & Biotechnology ETF in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
2,270% more capital invested
Capital invested by funds: $415K → $9.83M (+$9.42M)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
100% more funds holding
Funds holding: 3 → 6 (+3)
14.85% more ownership
Funds ownership: 2.24% → 17.09% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$10.6M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$328K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$130K |
| 4 |
AA
Advisory Alpha
Holland,
Michigan
|
+$25.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$381K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citigroup
New York
| $9.38M | +$10.6M | +187,500 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $291K | +$328K | +5,814 | New |
|
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $115K | +$130K | +2,308 | New |
|
4
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $24K | – | – | – |
|
|
AA
5
Advisory Alpha
Holland,
Michigan
| $21.8K | +$25.4K | +450 | New |
|
|
BFEC
6
Benjamin F. Edwards & Company
St. Louis,
Missouri
| $8K | – | – | – |
|
|
7
Jane Street
New York
| – | -$381K | -6,304 | Closed |
|
GNOM Hedge Fund Activity: Q3 2019 in Review
6 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q3 2019, worth a combined $9.83M — up 2,270% from $415K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GNOM positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $10.6M. The largest seller was Jane Street, exiting entirely with an estimated $381K sold.
- 6 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q3 2019, up from 3 in Q2 2019.
- Funds reported $9.83M of Global X Genomics & Biotechnology ETF stock for Q3 2019, up 2,270% quarter-over-quarter.
- 4 funds opened new Global X Genomics & Biotechnology ETF positions in Q3 2019 and 1 closed out, a net change of +3 holders.
- The largest Global X Genomics & Biotechnology ETF buyer in Q3 2019 was Citigroup, an estimated $10.6M added.
- The largest Global X Genomics & Biotechnology ETF seller in Q3 2019 was Jane Street, an estimated $381K sold.
Based on aggregated 13F filings for Q3 2019.